Acrivon Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2023 to Q4 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Acrivon Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2023 to Q4 2024.
Acrivon Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 1.27K %, a 18.7% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	1.27K	-292	-18.7%	Dec 31, 2024
Q3 2024	1.27K	-677	-34.8%	Sep 30, 2024
Q2 2024	1.32K	-581	-30.5%	Jun 30, 2024
Q1 2024	1.4K			Mar 31, 2024
Q4 2023	1.56K			Dec 31, 2023
Q3 2023	1.94K			Sep 30, 2023
Q2 2023	1.91K			Jun 30, 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.